Literature DB >> 20061993

Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity.

Jennifer A Wilking1, Kirstin G Hesterberg, Eric L Crouch, Gregg E Homanics, Jerry A Stitzel.   

Abstract

The reasons why people smoke are varied, but research has shown that genetic influences on various aspects of nicotine addiction are a major factor. There also is a strong genetic influence on measures of nicotine sensitivity in mice. Despite the established contribution of genetics to nicotine sensitivity in mice and humans, no naturally occurring genetic variation has been identified that demonstrably alters sensitivity to nicotine in either species. However, one genetic variant has been implicated in altering nicotine sensitivity in mice is a T529A polymorphism in Chrna4, the gene that encodes the nicotinic receptor (nAChR) alpha4 subunit. The Chrna4 T529A polymorphism leads to a threonine to alanine substitution at position 529 of the alpha4 subunit. To more definitively address whether the Chrna4 T529A polymorphism does, in fact, influence sensitivity to nicotine, knock-in mice were generated in which the threonine codon at position 529 was mutated to an alanine codon. Compared with Chrna4 T529 littermate controls, the Chrna4 A529 knock-in mice exhibited greater sensitivity to the hypothermic effects of nicotine, reduced oral nicotine consumption and did not develop conditioned place preference to nicotine. The Chrna4 A529 knock-in mice also differed from T529 littermates for two parameters of acetylcholine-stimulated Rb+ efflux in midbrain: maximal efflux and the percentage of alpha4beta2* receptors with high sensitivity to activation by agonists. Results indicate that the polymorphism affects the function of midbrain alpha4beta2* nAChRs and contributes to individual differences in several behavioral and physiological responses to nicotine thought to be modulated by midbrain alpha4beta2* nAChRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061993      PMCID: PMC2919848          DOI: 10.1097/FPC.0b013e3283369347

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  52 in total

1.  The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs.

Authors:  Heejeong Kim; Brody A Flanagin; Chuan Qin; Robert L Macdonald; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2003-09       Impact factor: 5.250

2.  Multiple components in the agonist concentration-response relationships of neuronal nicotinic acetylcholine receptors.

Authors:  P J Covernton; J G Connolly
Journal:  J Neurosci Methods       Date:  2000-03-01       Impact factor: 2.390

3.  Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers.

Authors:  Robert W B Brown; Allan C Collins; Jon M Lindstrom; Paul Whiteaker
Journal:  J Neurochem       Date:  2007-06-15       Impact factor: 5.372

4.  State-specific prevalence and trends in adult cigarette smoking--United States, 1998-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-03-13       Impact factor: 17.586

5.  Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism.

Authors:  Christopher M Butt; Nathan M King; Scott R Hutton; Allan C Collins; Jerry A Stitzel
Journal:  Behav Neurosci       Date:  2005-02       Impact factor: 1.912

6.  Purification and characterization of a nicotinic acetylcholine receptor from rat brain.

Authors:  P Whiting; J Lindstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus.

Authors:  Lorise C Gahring; Karina Persiyanov; Diane Dunn; Robert Weiss; Erin L Meyer; Scott W Rogers
Journal:  J Comp Neurol       Date:  2004-01-12       Impact factor: 3.215

8.  A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol.

Authors:  Christopher M Butt; Scott R Hutton; Jerry A Stitzel; Seth A Balogh; Jeremy C Owens; Allan C Collins
Journal:  Alcohol Clin Exp Res       Date:  2003-05       Impact factor: 3.455

9.  Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists.

Authors:  Sheri D Grabus; Billy R Martin; Sharon E Brown; M Imad Damaj
Journal:  Psychopharmacology (Berl)       Date:  2006-02-04       Impact factor: 4.530

10.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

View more
  16 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  The β3 subunit of the nicotinic acetylcholine receptor: Modulation of gene expression and nicotine consumption.

Authors:  Helen M Kamens; Jill Miyamoto; Matthew S Powers; Kasey Ro; Marissa Soto; Ryan Cox; Jerry A Stitzel; Marissa A Ehringer
Journal:  Neuropharmacology       Date:  2015-08-25       Impact factor: 5.250

4.  Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms.

Authors:  Stefan Ahrens; Sebastian Markett; Thomas P K Breckel; Oliver Behler; Martin Reuter; Christiane M Thiel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-03       Impact factor: 4.530

5.  Adolescent chronic variable social stress influences exploratory behavior and nicotine responses in male, but not female, BALB/cJ mice.

Authors:  M J Caruso; D E Reiss; J I Caulfield; J L Thomas; A N Baker; S A Cavigelli; H M Kamens
Journal:  Brain Res Bull       Date:  2017-08-09       Impact factor: 4.077

Review 6.  Recent advances in gene manipulation and nicotinic acetylcholine receptor biology.

Authors:  Anne Tammimäki; William J Horton; Jerry A Stitzel
Journal:  Biochem Pharmacol       Date:  2011-06-16       Impact factor: 5.858

7.  Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens.

Authors:  Anna M Lee; Robert O Messing
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

8.  Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.

Authors:  T D McClure-Begley; R L Papke; K L Stone; C Stokes; A D Levy; J Gelernter; P Xie; J Lindstrom; M R Picciotto
Journal:  J Pharmacol Exp Ther       Date:  2014-01-02       Impact factor: 4.030

Review 9.  Natural genetic variability of the neuronal nicotinic acetylcholine receptor subunit genes in mice: Consequences and confounds.

Authors:  Jennifer A Wilking; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

Review 10.  Translational research in nicotine dependence.

Authors:  Jill R Turner; Allison Gold; Robert Schnoll; Julie A Blendy
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.